T. Mera, D. Filipkowski, D. Riley, C. Whitney, B. Walter, S. Gunzler, J. Giuffrida Gait & Posture. 2013 May;38(1):109-14
Blog Archives
PRESS RELEASE: Great Lakes NeuroTechnologies Secures $1.7 Million to Develop Continuous Dyskinesia Monitoring Technology for Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 05 Mar 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching commercialization and clinical studies to validate a system for objective, continuous monitoring of dyskinesias associated with Parkinson’s disease. The…
PRESS RELEASE: Great Lakes NeuroTechnologies Launches Study to Develop Intelligent Algorithms for Programming Deep Brain Stimulation in Parkinson’s
VIEW PRESS RELEASE [PDF] 22 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching a study to determine the feasibility of using intelligent algorithms to assist with programming deep brain stimulation settings for…
PRESS RELEASE: Great Lakes NeuroTechnologies’ Kinesia Technology Receives TGA Approval for Parkinson’s Assessment in Australia
VIEW PRESS RELEASE [PDF] 9 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today that they received TGA approval to market Kinesia technology in Australia. The Kinesia™ product line [ http://glneurotech.com/kinesia/ ] includes patient-worn motion sensors and a…
Active-Assisted Cycling Improves Tremor and Bradykinesia in Parkinson’s Disease
A. Ridgel, C. Peacock, E. Fickes, C. Kim Arch Phys Med Rehabil. 2012 Nov;93(11):2049-54
PRESS RELEASE: GLNT Receives $1.5 Million to Further Technology for Assessing Bradykinesia Response to Novel Therapies in Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 08 AUG 2012: Valley View, OH – Great Lakes NeuroTechnologies [ http://www.glneurotech.com ] announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson’s disease (PD) patients that will better assess…
Tagged with: brady kinesia, company, dbs, deep brain stimulation, development, funding, growth, homeview, parkinson's disease, pd, pharmaceutical, stroke, symptom response, telemedicine, therapy, treatment, tremor, updrs
PRESS RELEASE: GLNT Launches Parkinson’s Technology In Europe For Quantitative Assessments In Telemedicine
VIEW PRESS RELEASE [PDF] 13 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they are launching the latest version of their medical device technology for assessing Parkinson’s disease next week at the Movement Disorders Society Congress…
Tagged with: clinical trial, clinical trials, company, dbs, deep brain stimulation, development, efficacy, growth, homeview, mds, motion sensor, parkinson's disease, pd, tablet, technology, telemedicine, web app
PRESS RELEASE: GLNT Issued Patent Claims For Technology To Assess Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 6 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that the U.S. Patent Office has issued claims under patent number 8,187,209 covering their Movement Disorder Monitoring System and Method for quantitative assessment of…
Patient Compliance with Parkinson’s Disease Home Monitoring System
Danielle Filipkowski, Dustin Heldman, Alberto Espay, Jaya Mishra, Thomas Mera, and J. Giuffrida 16th International Congress of Parkinson’s Disease and Movement Disorders, Dublin, Ireland 2012
Capturing Choreatic Dyskinesia Over Levodopa Dose Cycle in Parkinson’s Disease
T. Mera, Michelle Burack, MD, PhD, Frank Bonsignore, MS, J. Giuffrida, PhD 16th International Congress of Parkinson’s Disease and Movement Disorders, Dublin, Ireland 2012